Claranova (CLA) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
6 Jun, 2025Executive summary
Q3 2024-2025 revenue grew 4% at constant exchange rates, reaching €31m, with 9-month revenue at €91m, up 3% like-for-like.
SaaS subscription-based sales now represent 92% of total revenue, up from 89% last year.
The group is now focused on Avanquest, with PlanetArt and myDevices classified as discontinued operations and in the process of being sold.
Strategic transformation positions Claranova as a software publishing pure player, emphasizing profitability and sustainable growth.
Financial highlights
Q3 Avanquest revenue: €31m, up 4% at constant exchange rates and 2% at actual rates compared to Q3 last year.
9-month Avanquest revenue: €91m, up 3% like-for-like, but down 1% at actual exchange rates due to divestments.
Non-core activities' sales dropped to €7m (8% of total) from €10m a year earlier.
Outlook and guidance
Management aims to finalize the PlanetArt sale before the end of June 2025.
Focus remains on driving profitability and operational excellence under the "One Claranova" roadmap.
Latest events from Claranova
- EBITDA margin rose to 20.6% and net income turned positive amid a strategic B2B shift.CLA
H1 202625 Mar 2026 - Document segment growth and higher recurring revenue offset overall revenue decline.CLA
H1 2026 TU11 Feb 2026 - Revenue fell 7% as core SaaS focus and disciplined marketing drove improved profitability.CLA
Q1 202613 Nov 2025 - Net profit hit €73m, debt fell by €100m+, and SaaS focus lifted margins to 20.4%.CLA
H2 202531 Oct 2025 - SaaS focus, €118m revenue, 20% EBITDA margin, and major debt reduction drive growth.CLA
H2 2025 TU22 Aug 2025 - Q1 revenue stable at €89m; Avanquest up, myDevices down, 2027 targets reaffirmed.CLA
Q1 24/25 TU13 Jun 2025 - Stable revenue and improved profitability position Claranova for continued growth.CLA
H1 2025 TU5 Jun 2025 - EBITDA up 23% and net income quadrupled as software-focused transformation accelerates.CLA
H1 20255 Jun 2025